What if a microscopic molecule could detect cancer before symptoms even show up—or predict your risk of heart failure years in advance? That’s not science fiction anymore. It’s the promise of microRNA biomarkers, the latest revolution in precision diagnostics that’s turning heads across the healthcare industry. The MicroRNA Biomarker Market is rapidly gaining traction as...